Last $7.84 USD
Change Today -0.28 / -3.45%
Volume 58.3K
CCXI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitleKey Developments
Geoffrey Parker 21 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee 
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 
Ira Klein M.D., M.B.A., F.A.C.P 15 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitle
Joseph Feczko M.D. 36 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Roger Lucas Ph.D. 31 RelationshipsLead Independent Director and Member of Compensation Committee
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
CCXI Compensation vs. Industry
510.0K
319.9K
Chief Executive Officer
372.2K
233.5K
Chief Financial Officer
Share price activity for CHEMOCENTRYX INC (CCXI)
52 Week Price Performance
CCXI
Industry Average

Nominating Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitleKey Developments
Geoffrey Parker 21 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeChemoCentryx Appoints Israel F. Charo, Senior Vice President of Research
09/22/14
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeChemoCentryx, Inc. Appoints Anne-Marie S. Duliege as Executive Vice President, Chief of Strategic Development and Head of Immuno-Oncology
03/27/14
Joseph Feczko M.D. 36 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance CommitteeEdward Penhoet Intends to Resign from Board of Directors of ChemoCentryx, Inc
07/5/13
Ira Klein M.D., M.B.A., F.A.C.P 15 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeChemoCentryx, Inc. Announces the Appointment of Ira Klein to its Board of Directors
05/28/13

Corporate Governance Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitle
Joseph Feczko M.D. 36 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Ira Klein M.D., M.B.A., F.A.C.P 15 RelationshipsLead Independent Director and Member of Compensation Committee
Geoffrey Parker 21 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
James Tyree 45 Relationships--
CCXI and Competitor
Insiders vs. External
Board
6%
94%
ChemoCentryx, Inc.
17%
83%
Bristol-Myers Squibb Company
9%
91%
Biogen Idec Inc.
8%
92%
Teva Pharmaceutical Industries Limited
10%
90%
Incyte Corporation
37%
63%
Takeda Pharmaceutical Company Limited
Insiders
External Board Members

Advisory Committee* - chemocentryx inc (CCXI)

Name (Board Relationships)/Title Board Affiliations
Craig Gerard 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Hanauer 66 Relationships
Member of Clinical Advisory Board
No other board affiliations
Michael Kamm 15 Relationships
Member of Clinical Advisory Board
No other board affiliations
Daniel Littman 169 Relationships
Member of Scientific Advisory Board
No other board affiliations
Edward Mocarski 32 Relationships
Member of Scientific Advisory Board
No other board affiliations
Richard Ransohoff 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
William Sandborn 151 Relationships
Member of Clinical Advisory Board
No other board affiliations
Henry Showell 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Targan 51 Relationships
Member of Clinical Advisory Board
No other board affiliations
Sander van Deventer 85 Relationships
Member of Clinical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCXI:US $7.84 USD -0.28

CCXI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biogen Idec Inc $412.79 USD -3.00
Bristol-Myers Squibb Co $61.92 USD -0.38
Incyte Corp $87.95 USD -0.73
Takeda Pharmaceutical Co Ltd ¥6,390 JPY +88.00
Teva Pharmaceutical Industries Ltd $56.46 USD -0.70
View Industry Companies
 

Industry Analysis

CCXI

Industry Average

Valuation CCXI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 485.4x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 367.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMOCENTRYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.